Skip to main content

Table 2 Data extracted from "presented series"

From: Safety of percutaneous aortic valve insertion. A systematic review

Registry acronym Time window n Age Logistic EuroSCORE STS score Success rate (%) 30-d mort 6-m mort 1-yr mort Data source
Transfemoral Edwards Lifesciences PAVI
VANCOUVER Jan 2005 - NA 114 84° 28° 9.1° 92.1 7.9 13** 20** [39]
REVIVAL 2 Dec 2005 - Feb 2008 55 82.8 ± 6.8 34.1 ± 18.0 13.1 ± 7.2 87.3 7.3 16.6 24.2 [40, 41]
REVIVE 2 NA - Dec 2007 106 83.9 ± 5.4 29.9 ± 13.2 NA 88.0 13.2 21.4 28.6 [40, 41]
PARTNER EU April 2007 - Jan 2008 60 82.5 ± 5.2 24.7 ± 11.7 10.9 ± 5.9 96.3 7.4 10 NA [8]
SOURCE Nov 2007 - Sep 2008 293 81.8 26.4 NA 97.7 6.4 NA NA [8]
Transfemoral CoreValve PAVI
CoreValve 21F S&E Aug 2005 - 2006 52 81.4 ± 5.5 27.4 ± 15.1 NA 90.4 15.4 23** 35** [2]
CoreValve 18F S&E May 2006 - Oct 2007 124 81.8 ± 6.5 23.0 ± 13.5 NA 94.4 14.5 23** 28** [2]
CoreValve 18F EE April 2007 - Sep 2008 1243 81.2 ± 6.4 22.9 ± 14.1 NA 98.2 6.7 21° NA [2, 40]
TOTAL TRANSFEMORAL   2047      7.8    
Transapical Edwards Lifesciences PAVI
VANCOUVER Oct 2005 - NA 58 84° 28° 9.1° 98.3 19.0 34 34 [39]
REVIVAL 2 Dec 2005 - Feb 2008 40 83.7 ± 5.2 35.5 ± 15.3 13.4 ± 7.0 87.5 17.6 35.8 45.3 [3, 14]
TRAVERCE Dec 2004 - April 2008 168 82.0 ± 5.6 26.9 ± 12.8 NA 92.9 14.9 30 35 [41]
PARTNER EU April 2007 - Jan 2008 70 82.1 ± 5.7 33.5 ± 14.8 11.9 ± 7.0 91 18.6 42 NA [8]
SOURCE Nov 2007 - Sep 2008 309 80.7 30 NA NA 11.6 NA NA [42]
TOTAL TRANSAPICAL   645      13.8    
  1. Registry acronyms: VANCOUVER: Vancouver single-centre experience; REVIVAL 2: peRcutaneous EndoVascular Implantation of VALves; REVIVE 2: Registry of EndoVascular Implantation of Valves in Europe; PARTNER EU: Placement of AoRTic TraNscathetER Valve Trial; SOURCE: edwards Sapien aOrtic bioprothesis eURropean outComE registry; CoreValve 21F S&E: 21 French safety and efficacy registry; CoreValve 18F S&E: 18 French safety and efficacy registry; CoreValve 18F EE: 18 French post CE mark Expanded Evaluation registry; TRAVERCE: TRAnsapical Surgical DeliVEry of the Cribier-Edwards aortic bioprosthesis. TF: transfemoral. TA: transapical. PAVI: percutaneous aortic valve insertion. *: 18 French and 21 French refer to the outer diameter of the delivery sheath. **: estimated from Kaplan Meier survival plot. °: data from TF and TA series combined.